Market View: From Bank Margins to Bull Runs - Who’s Really Winning This Rally?
Asia-Pacific markets are flashing mixed signals - from softer bank profits to roaring equity rallies, so where is the opportunity for investors? DBS’ Q4 earnings remind investors that even best-in-cla...
9 Feb 25min
Where is Gold and Silver Going? From Record Highs to Violent Reversals
Gold and silver just gave investors a brutal reminder: safe havens can still whipsaw. After blistering rallies into early 2026, both metals have plunged as a stronger U.S. dollar, ETF unwinds and crow...
6 Feb 7min
Money and Me: The Great Convergence - Buying a Home When AI Is Shaking Your Paycheque
What if the real risk in buying a home isn’t interest rates - but your job? In early 2026, AI disruption, shifting HDB policies and volatile careers are forcing buyers to rethink what “affordable” rea...
6 Feb 17min
Market View: Amazon’s AI Bill, Crypto Chill & Earnings Whiplash
Amazon which posted solid headline profits, but saw a market recoil as expectations collide with a US$200bn AI spending plan. So why did Wall Street blink? AWS shines with robust margins and growth, u...
6 Feb 22min
Money and Me: Stop Letting Your SRS Sleep - How ETFs Turn Tax Relief into Real Returns
Many Singaporeans treat SRS as a “set it and forget it” tax tool, leaving cash idle at 0.05% while inflation does the damage. Hosted by Michelle Martin, this episode explores why investors are waking ...
5 Feb 25min
Market View: Google at $4 Trillion - When AI Lifts Giants and Spooks the Rest
Alphabet’s blockbuster quarter puts AI back in the spotlight as the tech giant delivers surging profits and resilient ad growth, even as markets turn jittery. Hosted by Michelle Martin with Ryan Huang...
5 Feb 22min
Money and Me: Buying China in One Click - From A500 ETFs to the Six AI Tigers
China’s investment narrative is shifting from old economy giants to new-generation growth engines. Michelle Martin speaks with Dr Wealth cofounder Alvin Chow, to explore whether the new CSI A500 index...
4 Feb 22min
Market View: Pharma Shockwaves, Singtel’s Deal Buzz & Big Tech’s Slide
Big Pharma’s report cards just rewrote the market mood. Market View dives into why Pfizer slipped into a quarterly loss, why Novo Nordisk plunged double digits, and how Merck managed to buck the trend...
4 Feb 22min
